Stay updated on Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now renders a 403 Forbidden error, signaling that the study page is inaccessible; a Home link appears as part of the error page's navigation.SummaryDifference0.5%

- Check12 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with an access-denied screen.SummaryDifference18%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedAdded NIH grant/contract attribution for 2016 and updated the documentation revision to v3.6.6, reflecting a minor metadata update.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5. This is a metadata version refresh that does not reflect changes to substantive content.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3, indicating a site version update. This is a metadata update and does not alter the study details or how users interact with the record.SummaryDifference0.0%

- Check90 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a small update to the study record.SummaryDifference0.0%

Stay in the know with updates to Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pegilodecakin and FOLFOX in Pancreatic Cancer Clinical Trial page.